🇺🇸 FDA
Patent

US 10383830

Modulating antibacterial immunity via bacterial membrane-coated nanoparticles

granted A61KA61K31/427A61K31/43

Quick answer

US patent 10383830 (Modulating antibacterial immunity via bacterial membrane-coated nanoparticles) held by The Regents of the University of California expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/427, A61K31/43, A61K31/49, A61K31/545